# Source and assumption ledger All financial amounts are CAD. Issuer PDFs in the owner inventory preserve original pagination. Public links below lead to the publisher. Dates refer to information available by November 19, 2026. | Input or calculation | Evidence and application | | --- | --- | | Food, pharmacy and front-store run rates | FY2025 category rows, plus 40-week 2026 less 40-week 2025. Remove the C$1,138m extra week pro rata to FY2025 category sales because its actual split was not disclosed in this table. [FY2025 category sales and 53rd-week adjustment, p. 32](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2025/LCL_2025%20Annual%20Report.pdf#page=32) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=1&text=additional%20trading%20week) [Q3 sales by category and comparable store sales, p. 12](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=12) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=1&text=Pharmacy%20and%20healthcare) | | Starting cash margin, rent, owned depreciation, reinvestment and tax | Peralta estimates 11.2%, 2.65%, 1.8%, initially 3.7% capex, and 27% tax. Q3 reported adjusted EBITDA margin 11.3%; trace cash rent components and capex to the cash statement. Owned depreciation is a normalized estimate excluding lease depreciation. Working-capital use of 0.1% smooths interim volatility. [Interim earnings and diluted shares, p. 46](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=46) [Interim cash flows, rent and capital purchases, p. 50](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=50) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=2&text=common%20repurchases) [Management outlook and gross capital expenditure, p. 28](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=28) | | Equity bridge | Cash, borrowings, associate interest, NCI and unconsolidated investments from October balance sheet. Quarterly diluted weighted-average share count from EPS note. [Interim balance sheets, p. 49](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=49) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=3&text=Associate%20interest) [Note 9, EQB and other investments, p. 58](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=58) [Interim earnings and diluted shares, p. 46](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=46) | | Market inputs | November 19 CAD close and 10-year Canada yield. 5% market premium, 5% pretax borrowing, 90/10 weights, 0.8 policy beta and 2.5% terminal growth are assumptions. 52- and 156-week alternatives are reproduced using adjusted weekly closes through the last completed week. [Loblaw TSX daily closing prices](https://finance.yahoo.com/quote/L.TO/history/) [Bank of Canada, 10-year benchmark yield, Nov 19](https://www.bankofcanada.ca/valet/observations/BD.CDN.10YR.DQ.YLD/json?start_date=2026-11-19&end_date=2026-11-19) [XIC history](https://finance.yahoo.com/quote/XIC.TO/history/) | | Growth and payout | Category growth and fade, required hurdle, terminal growth, tax, fee and margin stress are explicit in inputs.json. The five-year calculation assumes distributable cash after interest accrues to holders and fixed balance-sheet claims. It approximates a total return; actual dividends, buybacks and financing policy will differ. [Q3 sales by category and comparable store sales, p. 12](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=12) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=1&text=Pharmacy%20and%20healthcare) [Management outlook and gross capital expenditure, p. 28](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=28) | | Statements, peer inputs and voting | Original annual/interim table rows and comparable periods are retained in statements.py. The comparison uses the latest disclosed quarter for each issuer. [Annual cash flows and shareholder distributions, p. 106](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2025/LCL_2025%20Annual%20Report.pdf#page=106) [Annual earnings from continuing and discontinued operations, p. 102](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2025/LCL_2025%20Annual%20Report.pdf#page=102) [Annual balance sheets, p. 105](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2025/LCL_2025%20Annual%20Report.pdf#page=105) [Interim cash flows, rent and capital purchases, p. 50](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=50) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=2&text=common%20repurchases) [Interim earnings and diluted shares, p. 46](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=46) [Interim balance sheets, p. 49](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/LCL_Q3%202026_RTS.pdf#page=49) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=3&text=Associate%20interest) [Metro earnings and cash operating costs, p. 17](https://corpo.metro.ca/userfiles/file/PDF/Rapport-trimestriel/2026/2026-Fourth-Quarter-Results.pdf#page=17) [Empire earnings and equity income, p. 27](https://www.empireco.ca/uploads/2026/09/Q1F27-Empire-Quarterly-Report-SEDAR.pdf#page=27) [Record-date voting rights and beneficial ownership, p. 11](https://dis-prod.assetful.loblaw.ca/content/dam/loblaw-companies-limited/creative-assets/loblaw-ca/investor-relations-reports/annual/2026/2026%20Loblaw%20Management%20Proxy%20Circular_EN.pdf#page=11) · [Highlighted Peralta exhibit](sources/peralta-evidence.pdf#page=4&text=Record-date%20control) |